Report: Proteomics: Technologies and Global Markets TOC

Chapter-1: SUMMARY 2

SUMMARY TABLE GLOBAL PROTEOMICS MARKET BY EQUIPMENT, DATABASE AND SOFTWARE, TECHNOLOGY, AND SERVICES, THROUGH 2014 ($ MILLIONS) 5
SUMMARY FIGURE GLOBAL PROTEOMICS MARKET BY EQUIPMENT, DATABASE AND SOFTWARE, TECHNOLOGY, AND SERVICES, 2007-2014 ($ MILLIONS) 6

Chapter-2: MARKET OVERVIEW 21

FIGURE 1 EVOLUTION OF PROTEOMICS AND FUTURE TRANSITION 7
DEFINING THE PROTEOMICS MARKET 8
FIGURE 2 PROTEOMICS MARKET DEFINITION CHART 9
TECHNOLOGICAL INNOVATION BOOSTING PROTEOMICS EQUIPMENT MARKET 10
FIGURE 3 RELATIVE IMPORTANCE OF PROTEOMICS SYSTEMS AND TECHNOLOGY ISSUES 10
FIGURE 4 BCG MATRIX FOR PROTEOMICS EQUIPMENT MARKET, 2009 11
TECHNOLOGY REMAINS THE KEY ENABLER 12
FIGURE 5 PATENT ANALYSIS BY TECHNOLOGY, 2006 (%) 13
FIGURE 6 PATENT ANALYSIS BY TECHNOLOGY, 2008 (%) 14
EMERGENCE OF PROTEOMICS SERVICES MARKET 15
FIGURE 7 BCG MATRIX FOR PROTEOMICS SERVICE MARKET - ANALYTICAL LABORATORY SERVICES, 2009 15
KEY FACTORS INFLUENCING THE PROTEOMICS MARKET 16
FIGURE 8 KEY MARKET FACTORS INFLUENCING THE GROWTH OF PROTEOMICS 17
PROTEOMICS MARKET LED BY U.S. CENTRIC PLAYERS 17
FIGURE 9 PATENT ANALYSIS BY ASSIGNEE, 2009* (%) 18
INCREASING ADOPTION OF PROTEOMICS IN DRUG DISCOVERY 19
FIGURE 10 CURRENT AND FUTURE POTENTIAL FOR PROTEOMICS APPLICATION MARKET 20
EQUIPMENT PROVIDERS ARE KEY EARNERS AND DRUG DISCOVERY COMPANIES ARE KEY INVESTORS 20
FIGURE 11 SUPPLY SIDE STAKEHOLDER ANALYSIS, 2009 (%) 21
FIGURE 12 DEMAND SIDE STAKEHOLDER ANALYSIS, 2009 (%) 22
MARKET DRIVERS 22
DRAWBACKS OF GENOMICS IGNITING THE GROWTH OF PROTEOMICS: 22
NEED TO IMPROVE THE SPEED AND EFFICIENCY OF DRUG DISCOVERY 23
PROTEOMICS LEADS TO INCREASE IN R&D PRODUCTIVITY 23
CONTINUED DEVELOPMENT OF TECHNOLOGIES 23
CAPABILITY OF PROTEOMICS IN DEVELOPING PERSONALIZED THERAPY 24
LOWER SAMPLE REQUIREMENTS LEADS TO COST EFFECTIVENESS 24
IDENTIFICATION OF 3-D STRUCTURE OF PROTEINS AIDS IN DRUG DESIGN 24
MULTI-TASKING PLATFORMS CONFIRM THE ROLE OF TARGET PROTEINS IN DISEASE 24
MARKET INHIBITORS 25
MASSIVE DIVERSIFIED DATA LEADS TO THE NEED OF STRUCTURING A STANDARD FORM 25
STRUCTURING OF PROTEINS REQUIRES EXPENSIVE TOOLS AND MACHINES LEADING TO LOWER ADOPTION RATES 25
NEED FOR WELL-QUALIFIED RESEARCHERS AND MANDATORY TRAINING, INCREASES THE COST FACTOR 25
COST AND REIMBURSEMENT COMPLEXITIES EMERGING AS MAJOR HINDRANCES 26
NEED FOR MORE SOPHISTICATED TOOLS FOR HIGHER-END ANALYSIS 26
RIGID STRUCTURE OF PROTEINS COMPLICATE FURTHER RESEARCH 26
LACK OF TECHNOLOGIES TO SPEED UP VALIDATION PROCESS 26
OPPORTUNITIES 27
BIO MARKER IDENTIFICATION OPENING OPPORTUNITIES 27
COMBINATION OF PROTEOMICS AND METAOLOME STUDIES COULD LEAD TO EFFECTIVE PERSONALIZED MEDICINES 27
THE INTEREST OF PROTEOMICS PRODUCTS AND SERVICE SUPPLIERS ENSURES GROWTH OF PROTEOMICS 27
PROTEOMICS DATA ANALYSIS LEADS TO MORE AND IMPROVED DRUGS 27

Chapter-3: GLOBAL PROTEOMICS EQUIPMENT MARKET 60

TABLE 1 GLOBAL PROTEOMICS EQUIPMENT MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 28
TABLE 2 GLOBAL PROTEOMICS EQUIPMENT MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 29
PROTEIN CHIPS AND MICROARRAYS 29
TABLE 3 GLOBAL PROTEIN CHIPS AND MICROARRAYS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 30
TABLE 4 GLOBAL PROTEIN CHIPS AND MICROARRAYS MARKET, THROUGH 2014 ($ MILLIONS) 30
TOP PLAYERS 30
TABLE 5 RECENT DEVELOPMENTS 31
BIOCHIPS/SLIDES 31
TABLE 6 GLOBAL BIO CHIPS/SLIDES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 32
Market Drivers 32
Measurement Done by Protein Biochips is Much Easier than Other Traditional Methods of Research 32
Protein Biochips Take Less Time for Analysis, which Makes Them Favorites for Protein Expression Profiling 32
Presence of Competitive Methods for Protein Identification Acts as an Obstacle for Protein Biochips 33
MICROARRAYS 33
TABLE 7 GLOBAL MICROARRAYS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 33
TABLE 8 GLOBAL MICROARRAYS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 34
Market Drivers 34
Multi Processing Capacity of Microarrays Driving its Adoption Rate in Proteomics 34
Microarrays Provide Complete Protein Profiling Leading to its Utilization in Basic Research 34
Minimal Use of Materials Makes Microarrays an Inexpensive Technology 35
Use of Recombinant Methods Establishes Direct Connectivity between DNA Sequences 35
Growth of Pharmaceutical Industry is Leading to the Growth of the Microarray Market 35
SCANNERS 35
TABLE 9 GLOBAL SCANNERS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 36
INTEGRATED SYSTEMS 36
TABLE 10 GLOBAL INTEGRATED SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 36
PROTEIN ANALYSIS SYSTEM/PROTEOMICS SYSTEM 37
TABLE 11 GLOBAL PROTEIN ANALYSIS SYSTEM/PROTEOMICS SYSTEM MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 37
TABLE 12 GLOBAL PROTEIN ANALYSIS SYSTEM/PROTEOMICS SYSTEM MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 38
PROTEIN-PROTEIN INTERACTION/AFFINITY CHARACTERIZATION SYSTEMS 38
TABLE 13 GLOBAL PROTEIN-PROTEIN INTERACTION/AFFINITY CHARACTERIZATION MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 38
MEMBRANE PROTEIN ANALYSIS SYSTEMS 39
TABLE 14 GLOBAL MEMBRANE PROTEIN ANALYSIS SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 39
PROTEIN INTERCATION MONITORING SYSTEMS - REAGENTS 39
TABLE 15 GLOBAL PROTEIN INTERACTION MONITORING SYSTEMS REAGENTS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 40
PROTEIN FRACTIONATION SYSTEMS 40
TABLE 16 GLOBAL PROTEIN FRACTIONATION SYSTEM MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 40
SPR SYSTEMS 41
TABLE 17 GLOBAL SPR SYSTEM MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 41
2-DE MARKET 42
TABLE 18 GLOBAL 2-DE MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 42
TABLE 19 GLOBAL 2-DE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 43
MARKET DRIVERS 43
Enhanced Features of This System Lead to Higher Throughput 43
Collection of Substantial Amount of Information through Image Analysis and Data Mining Solutions 43
Investments by Researchers Leading To the Growth of This System 44
This System Consumes Time and is Labor Intensive 44
RECENT DEVELOPMENTS 44
2-DGE SYSTEMS 44
TABLE 20 GLOBAL 2-DGE SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 44
Market Drivers 45
Growth of 2-DGE Market Ignites the Growth for 2-DGE Systems 45
Use of 2-DGE in Medical Applications Escalating Demand for Proteomics Systems: 45
2-DE Systems Complement Other Techniques, Which Adds to Their Application Portfolio: 45
Difficulties Associated with 2-D Gels Restrict 2-DE Systems from Being Used at Full Potential 45
ISOELECTRIC FOCUSING SYSTEMS (FRACTIONATORS, GELS, AND STRIPS) 46
TABLE 21 GLOBAL ISOELECTRIC FOCUSING SYSTEMS (FRACTIONATORS, GELS, AND STRIPS) MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 46
Market Drivers 46
Multi-Metric Composition Leading to High Resolution and Purity of Samples 46
Negligible Interactions with Metal Ions 47
User Friendly 47
Others Factors Driving the Market 47
2-DE CELLS 47
TABLE 22 GLOBAL 2-DE CELLS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 47
2-D PROTEIN MW MARKERS 48
TABLE 23 GLOBAL 2-D PROTEIN MW MARKERS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 48
MF CHIP TECHNOLOGY/MF SYSTEMS 48
TABLE 24 GLOBAL MF CHIP TECHNOLOGY/MF SYSTEM MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 49
TABLE 25 GLOBAL MF CHIP TECHNOLOGY/MF SYSTEM MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 49
MARKET DRIVERS 49
A Tool for Analyzing the Drug' s Effectiveness, Pharmacological Profiling, and Toxicity Testing 50
Significant Contribution to the Field of Diagnosis and Treatment 50
Helpful In the Detection of Various Non-Communicable Diseases 50
A Significant Role in the Field of Quality Control 50
Minimum Wastage, Low Reagents Costs, and Less Requirement of the Sample Volume for Diagnostics 50
Others 51
MARKET INHIBITORS 51
LOC is a Novel Technology that Requires Further Refinement 51
Precision Engineering Still Remain Comparatively Sophisticated 51
TOP PLAYERS 52
TABLE 26 RECENT DEVELOPMENTS 52
MF CHIPS AND CHIPS-BASED IMMUNOASSAYS 52
TABLE 27 GLOBAL MF CHIPS AND CHIP-BASED IMMUNOASSAYS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 53
MARKET DRIVERS 53
Cost-Effective Complex Analysis System Can Be Developed on a MF Chip 53
MF Chip Acts as an Essential Tool for MS 53
Complete Automation in a Single Device Leads to Reduction in Accidental Loss of Reagents 54
Microchips Enable Greater Speed and Higher Quality of Output 54
The Minimal Requirement of Samples Results in Cost Reduction 54
MF Chip Technology Unable to Mix Fluids on the Chips in an Effective Manner, Making Them Less Favorable for Analysis of Complex Fluids 54
HTS 54
TABLE 28 GLOBAL HTS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 55
MARKET DRIVERS 55
A Tool for Speedy Accomplishment of Biochemical, Genetic, or Pharmacological Tests 55
Demand in Academia 56
The Combination of HTS and uHTS Has a Lot of Advantages 56
HTS Increases Cost-Effectiveness and Productivity 56
Others 56
MICROSPHERE ANALYSIS 57
TABLE 29 GLOBAL MICROSPHERE ANALYSIS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 57
TABLE 30 GLOBAL MICROSPHERE ANALYSIS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 57
ASSAY REAGENTS (MICROSPHERE) 58
TABLE 31 GLOBAL FLUORESCENT MICROSPHERE ASSAY AND REAGENT MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 58
MULTIPLEX ASSAY SYSTEM/FLUORESCENCE MULTIPLEX ARRAYS 58
TABLE 32 GLOBAL MULTIPLEX ASSAY SYSTEMS/FLUORESCENCE MULTIPLEX ARRAYS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 59
MICROSPHERES AND ASSAY KITS 59
TABLE 33 GLOBAL MICROSPHERES AND ASSAY KITS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 60
MS 60
TABLE 34 GLOBAL MS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 60
TABLE 35 GLOBAL MS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 61
MARKET DRIVERS 61
Simple Quantification of Protein Structures Generates the Need for MS 61
MS Acts as a Supporting Element for Growing Technologies 61
Gaining Popularity of Hybrid MS Instruments is Boosting the Growth for MS 61
MARKET INHIBITORS 62
MS Fails to Analyze Small Quantities of Proteins 62
Manual Interruption Necessary, Increasing the Error Rate 62
TOP PLAYERS 62
TABLE 36 RECENT DEVELOPMENTS 62
TABLE 36 (CONTINUED) 63
IONIZATION SOURCES 63
TABLE 37 GLOBAL IONIZATION SOURCES MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 64
TABLE 38 GLOBAL IONIZATION SOURCES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 64
MALDI 64
TABLE 39 GLOBAL MALDI MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 65
ESI 65
TABLE 40 GLOBAL ESI MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 65
Atmospheric Pressure Chemical Ionization (APCI) 66
TABLE 41 GLOBAL APCI MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 66
MASS ANALYZERS 66
TABLE 42 GLOBAL MASS ANALYZERS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 67
OTHERS 67
TABLE 43 GLOBAL OTHER EQUIPMENT MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 67
TABLE 44 GLOBAL OTHER EQUIPMENT MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 68
REAGENTS AND ANTIBODIES 68
TABLE 45 GLOBAL REAGENT AND ANTIBODIES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 68
AUTOMATED LIQUID HANDLING WORKSTATIONS 69
TABLE 46 GLOBAL AUTOMATED LIQUID HANDLING WORKSTATIONS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 69
SPOT PICKERS 69
TABLE 47 GLOBAL SPOT PICKERS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 70
TOP PLAYERS 70
RECENT DEVELOPMENTS 70
Agreements and Collaborations (December 8, 2008) 70
CHROMATOGRAPHY SYSTEMS 71
TABLE 48 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 71
TABLE 49 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 72
MARKET DRIVERS 72
LC/MS SYSTEMS 73
TABLE 50 GLOBAL LC/MS SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 73
TOP PLAYERS 74
TABLE 51 RECENT DEVELOPMENTS 74
HPLC SYSTEMS 74
TABLE 52 GLOBAL HPLC SYSTEMS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 75
TABLE 53 GLOBAL HPLC SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 75
ION CHROMATOGRAPHY SYSTEMS 76
Market Drivers 76
Reduces the Analysis Time Leading to Higher Efficiency 76
Higher Sensitivity Ensuring Higher Accuracy Levels 76
Simultaneous Detection of Numerous Samples 76
TABLE 54 GLOBAL ION CHROMATOGRAPHY SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 76
NANOSCALE HPLC SYSTEMS 77
TABLE 55 GLOBAL NANOSCALE HPLC SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 77
GC/MS SYSTEMS 77
TABLE 56 GLOBAL GC/MS SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 78
TOP PLAYERS 78
TABLE 57 NEW PRODUCT DEVELOPMENT 79
COMPLETE PROTEIN PURIFICATION SYSTEMS 79
Market Drivers 79
User Friendly 79
Speedy and Suitable Start to All Purification 79
TABLE 58 GLOBAL COMPLETE PROTEIN PURIFICATION SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 80
GEL PERMEATION CHROMATOGRPAHY SYSTEMS 80
TABLE 59 GLOBAL GEL PERMEATION CHROMATOGRAPHY SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 81
COMPLETE LC-NMR-MSN SYSTEMS 81
TABLE 60 GLOBAL COMPLETE LC-NMR-MSN SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 81
Market Drivers 82
CHROMATOGRAPHY SYSTEM ACCESSORIES 82
Market Drivers 82
TABLE 61 GLOBAL CHROMATOGRAPHY SYSTEM ACCESSORIES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 83
SUPERCRITICAL FLUID CHROMATOGRAPHY AND EXTRACTION SYSTEMS 83
TABLE 62 GLOBAL SUPERCRITICAL FLUID CHROMATOGRAPHY AND EXTRACTION MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 84
CAPILLARY LC SYSTEMS 84
TABLE 63 GLOBAL CAPILLARY LC SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 85
AUTOMATED SPE SYSTEMS 85
TABLE 64 GLOBAL AUTOMATED SPE SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 86
Market Growth 86
These Systems Are Good Platforms for Direct Injections of Plasma, Urine, Vegetable Oils, and Surface Water 86
These Systems Automate Cleaning of Sample and Analyte Enrichment 86
These Systems Eliminate Traditional Manual Sample Steps, Making Them Inexpensive Platforms for Speedy Analysis 86
Other Driving Factors 87
Need for Human Intervention Absorbs Enormous Time 87

Chapter-4: PROTEOMICS TECHNOLOGY MARKET 18

TABLE 65 GLOBAL PROTEOMICS TECHNOLOGY MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 88
TABLE 66 GLOBAL PROTEOMICS TECHNOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 88
BASED ON TYPES 89
TABLE 67 GLOBAL PROTEOMICS TECHNOLOGY MARKET BASED ON PRODUCT TYPES, THROUGH 2014 ($ MILLIONS) 89
TABLE 68 GLOBAL PROTEOMICS TECHNOLOGY MARKET BASED ON TYPES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 89
STRUCTURAL PROTEOMICS 89
TABLE 69 GLOBAL STRUCTURAL PROTEOMICS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 90
TABLE 70 GLOBAL STRUCTURAL PROTEOMICS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 90
X-Ray Crystallography 90
TABLE 71 GLOBAL X-RAY CRYSTALLOGRAPHY MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 91
Market Drivers 92
Application in Drug Discovery Boosting Market Growth 92
Simple and Low Cost Solution Increasing Adoption Rates 92
Aids Effective Analysis in Short Span of Time 92
Top Players 92
TABLE 72 ACQUISITIONS/MERGERS/JOINT VENTURES 93
Recent Developments 93
March 27, 2008 Agreements and Collaborations 93
NMR Spectroscopy 93
TABLE 73 GLOBAL NMR SPECTROSCOPY MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 94
EXPRESSIONAL PROTEOMICS 95
TABLE 74 GLOBAL EXPRESSIONAL PROTEOMICS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 95
TABLE 75 GLOBAL EXPRESSIONAL PROTEOMICS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 95
Serial Analysis of Gene Expression (SAGE) 96
TABLE 76 GLOBAL SAGE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 96
DNA Chips 97
TABLE 77 GLOBAL DNA CHIPS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 97
Top Players 97
TABLE 78 RECENT DEVELOPMENT 98
BASED ON PROCESS 98
TABLE 79 GLOBAL PROTEOMICS TECHNOLOGY BASED ON PROCESS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 98
TABLE 80 GLOBAL PROTEOMICS TECHNOLOGY BASED ON PROCESS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 99
PROTEIN, IDENTIFICATION, SEQUENCING, AND CHARACTERIZATION 99
TABLE 81 GLOBAL PROTEIN, IDENTIFICATION, SEQUENCING, AND CHARACTERIZATION MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 99
TABLE 82 GLOBAL PROTEIN, IDENTIFICATION, SEQUENCING, AND CHARACTERIZATION MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 100
Top Players 100
TABLE 83 RECENT DEVELOPMENT 100
TABLE 83 (CONTINUED) 101
TANDEM MASS SPETROMETRY (TD/MS) 101
TABLE 84 GLOBAL TANDEM MS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 102
CIRCULAR DICHROISM (CD) 102
TABLE 85 GLOBAL CD MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 102
SAMPLE PREPARATION 103
TABLE 86 GLOBAL SAMPLE PREPARATION MARKET BY PRODUCT, THROUGH 2014 ($ THOUSANDS) 103
TABLE 87 GLOBAL SAMPLE PREPARATION MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 103
Top Players 104
Recent Developments 104
April 23, 2009: New Product Launch 104
CE SYSTEMS 104
TABLE 88 GLOBAL CE SYSTEMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 104
PRESSURE CYCLING TECHNOLOGY 105
TABLE 89 GLOBAL PRESSURE CYCLING TECHNOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 105

Chapter-5: PROTEOMICS SERVICES MARKET 8

TABLE 90 GLOBAL PROTEOMICS SERVICES MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 106
TABLE 91 GLOBAL PROTEOMICS SERVICES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 106
ANALYTICAL LABORATORY SERVICES 107
TABLE 92 GLOBAL ANALYTICAL LABORATORY SERVICES MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 107
TABLE 93 GLOBAL ANALYTICAL LABORATORY SERVICES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 107
QUALITY CONTROL OF PROTEINS AND PROTEIN IDENTIFICATION 108
PROTEIN SEPARATION SERVICES 108
PROTEIN SEQUENCING SERVICE 109
DATA ANALYSIS AND MAINTENANCE 109
TABLE 94 GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET BY PRODUCT, THROUGH 2014 ($ THOUSANDS) 110
TABLE 95 GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 110
TABLE 96 GLOBAL BIOINFORMATICS AND COMPUTATIONAL PROTEOMICS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 111
Top Players 111
TABLE 97 RECENT DEVELOPMENTS 111
TABLE 97 (CONTINUED) 112
DOCUMENT ANALYSIS AND DATA MINING SERVICES 112
TABLE 98 GLOBAL DOCUMENT ANALYSIS AND DATA MINING SERVICES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 112
Top Players 113
Recent Developments 113
April 7, 2009 Agreements and Collaborations 113

Chapter-6: PROTEOMICS DATABASE AND SOFTWARE MARKET 26

TABLE 99 GLOBAL PROTEOMICS DATABASE AND SOFTWARE MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 114
TABLE 100 GLOBAL PROTEOMICS DATABASE AND SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 115
PROTEOMICS SOFTWARE 115
OPPORTUNITIES 115
Proteomics Software Vendors' Interest is Opening New Opportunities for This Market 116
Association with Academics Labs for Progression In Proteomics Software Ensures Growth In Near Future 116
Collaborations of Proteomics Software Providers with Institutes Open Up New Opportunities 116
TABLE 101 GLOBAL PROTEOMICS SOFTWARE MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 116
TABLE 101 (CONTINUED) 117
TABLE 102 GLOBAL PROTEOMICS SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 117
MARKET DRIVERS 117
Proteomics Software Aids in Dynamic Analysis with Higher Throughput 117
Identifying Low Abundance Proteins 118
Detecting Post-Translational Modifications 118
Use of Proteomics Software Leads to Better Quantitation of Proteomics Data 118
Implementation and Integration of This Software Need the Attention of Experienced Personnel, which Demands Time and Resources 118
MS SOFTWARE 118
TABLE 103 GLOBAL MS SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 119
Top Players 119
PROTEIN VALIDATION AND QUANTIFICATION TECHNOLOGIES 120
TABLE 104 GLOBAL PROTEIN VALIDATION AND QUANTIFICATION TECHNOLOGIES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 121
MICROARRAY SOFTWARE 121
TABLE 105 GLOBAL MICROARRAY SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 121
MF CHIP INSTRUMENT SOFTWARE 122
TABLE 106 GLOBAL MF CHIP INSTRUMENT SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 122
PROTEIN STRUCTURAL ANALYSIS 122
TABLE 107 GLOBAL PROTEIN STRUCTURAL ANALYSIS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 123
TANDEM MASS SPEC PROTEOMICS DATA VIEWER 123
TABLE 108 GLOBAL TANDEM MASS SPEC PROTEOMICS DATA VIEWER MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 123
PRIMER ANALYSIS 124
TABLE 109 GLOBAL PRIMER ANALYSIS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 124
PROTEIN AND PEPTIDE IDENTIFICATION SOFTWARE 125
TABLE 110 GLOBAL PROTEIN AND PEPTIDE IDENTIFICATION SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 125
PROTEIN SEQUENCE AND PLASMID DRAWING ANALYSIS 126
TABLE 111 GLOBAL PROTEIN SEQUENCE AND PLASMID DRAWING ANALYSIS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 127
GEL IMAGE ANALYSIS SOFTWARE 127
TABLE 112 GLOBAL GEL IMAGE ANALYSIS SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 128
PROTEOMICS DATABASES 128
TABLE 113 GLOBAL PROTEOMICS DATABASES MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 128
TABLE 114 GLOBAL PROTEOMICS DATABASES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS) 129
PROTEIN-PROTEIN INTERACTION 129
TABLE 115 GLOBAL PROTEIN-PROTEIN INTERACTION MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 130
Top Players 130
TABLE 116 RECENT DEVELOPMENTS 130
TABLE 116 (CONTINUED) 131
PROTEIN SEQUENCE DATABASE 131
TABLE 117 GLOBAL PROTEIN SEQUENCE DATABASE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 132
Top Players 132
Recent Development 132
April 3, 2009: New Technology Launch 132
PROTEINS AND GENES 132
TABLE 118 GLOBAL PROTEINS AND GENES MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 133
GENE ONTOLOGY 133
TABLE 119 GLOBAL GENE ONTOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 133
3-D STRUCTURES OF PROTEIN 134
TABLE 120 GLOBAL 3-D STRUCTURES OF PROTEIN MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 134
TABLE 121 RECENT DEVELOPMENT 134
TABLE 121 (CONTINUED) 135
GENERAL INFORMATION DATABASES 135
TABLE 122 GLOBAL GENERAL INFORMATION DATABASE MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 135
Top Players 136
TABLE 123 RECENT DEVELOPMENTS 136
GENERAL LABORATORY SOFTWARE PROGRAMS 136
TABLE 124 GLOBAL GENERAL LABORATORY SOFTWARE PROGRAMS MARKET BY PRODUCT, THROUGH 2014 ($ THOUSANDS) 136
TABLE 125 GLOBAL GENERAL LABORATORY SOFTWARE PROGRAMS MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($THOUSANDS) 137
DESKTOP DATABASE, MANAGEMENT PROGRAMS, AND OPERATING SYSTEMS 137
TABLE 126 GLOBAL DESKTOP DATABASE, MANAGEMENT PROGRAMS, AND OPERATING SYSTEMS MARKET BY REGION, THROUGH 2014 ($ THOUSANDS) 137
IMAGE PROCESSING AND ANALYSIS SOFTWARE PROGRAM 138
TABLE 127 GLOBAL IMAGE PROCESSING AND ANALYSIS SOFTWARE PROGRAM MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 138
GRAPHING SOFTWARE PROGRAM 139
TABLE 128 GLOBAL GRAPHING SOFTWARE PROGRAM MARKET BY GEOGRAPHIC REGION, THROUGH 2014 ($ THOUSANDS) 139

Chapter-7: PROTEOMICS APPLICATIONS MARKET 14

TABLE 129 GLOBAL PROTEOMICS APPLICATIONS MARKET THROUGH 2014 ($ MILLIONS) 140
DRUG DISCOVERY 140
TABLE 130 GLOBAL DRUG DISCOVERY APPLICATIONS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 141
MARKET DRIVERS 141
Shortcomings of Gene-Based Drug Discovery Igniting Adoption of Proteomics 141
Benefits Derived through Protein-Based Drug Design and Discovery Are Expected to Be the Key Factor Contributing to Growth of Proteomics in the Drug Discovery Market 141
Need to Understand the Dynamics of Protein Element 142
Continuous Search for Alternative and Efficient Methods to Deliver Enhanced Drugs 142
Increasing R&D Investments from Pharmaceutical and Biotech Companies 142
Potential Market in Growing Economies 143
Emerging Approaches and Innovations in Proteomics Improving Decision Support Tools 143
MARKET INHIBITORS 143
Lack of Enhanced Computational Tools Limiting the Scope of Effective Analysis 143
Limited Drug Alternatives Restricting the Scope of Proteomics 144
Prevailing Skepticism on the Feasibility of Manufacturing Protein-Based Drugs on Larger Levels, Impairing the Adoption of Proteomics 144
Limited Utility of Proteomics Due to Complexity Involved and Lack of Adequately Trained Manpower 144
DRUG DEVELOPMENT 144
DRUG TARGET VALIDATION 145
MARKET DRIVERS 145
Advantages of Target-Based Drug Discovery Leading to Profuse Investment from Drug Development Companies 145
Application of Proteomics Enabling Process Efficiency 145
Limited Knowledge on Protein Dynamics Limits High-Level Application 146
ADME-TOX Profiling 146
Target Identification 146
DIAGNOSIS MARKET 147
TABLE 131 GLOBAL DIAGNOSIS APPLICATIONS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 147
MARKET DRIVERS 147
Better Analysis of Kidney Diseases by Proteomics Supports Its Growth in Clinical Application 147
Determination of Protein Expression for Normal and Diseased States Spurs the Use of Proteomics as a Diagnostic Tool 148
Continuous Advancements in the Proteomics Technologies 148
MARKET INHIBITORS 148
Complexity of Proteomes Acts as a Barrier for the Use of Proteomics in Diagnostic Applications 148
Inability of Proteomic Diagnostic Tools to Give Accurate and Reproducible Results Slows Down Its Growth 148
NEW BIOMARKER 148
Market Drivers 149
High-Quality Proteomics Equipment Have Effectively Helped in Biomarker Detection in Complex Mixtures 149
Biomarker Detection for Excessive Alcohol Consumption is becoming a Popular Area for Proteomics 149
Market Inhibitors 149
Inability to Detect Some Important Biomarkers by Proteomics Tools Restricts Its Adoption in New Biomarker Application 149
A High Cost and Time Requirement for Biomarker Detection by Proteomics Experiments Confines the Use of Proteomics 150
PROTEIN-PROTEIN INTERACTION 150
PROTEIN QUANTIFICATION 150
PROTEIN PURIFICATION 150
PROTEIN IDENTIFICATION 151
GLOBAL THERAPY AND OTHERS MARKET 151
TABLE 132 GLOBAL THERAPY AND OTHERS APPLICATIONS MARKET BY PRODUCT, THROUGH 2014 ($ MILLIONS) 151
THERAPY 152
Market Drivers 152
Proteomics Application in Anesthesiology is Evolving as a New Area in Therapy 152
Proteomics Is Gaining Popularity as a Cancer Diagnostic Tool 152
Market Inhibitors 152
Proteomics-Based Therapy Market Still Not an Established Segment 152
Cost of Therapy Limiting the Scope 152
FOOD AND NUTRITION 153
HOMELAND SECURITY 153

Chapter-8: GEOGRAPHIC ANALYSIS OF PROTEOMICS MARKET 5

20/20 GENESYSTEMS, INC. 159
TABLE 137 20/20 GENESYSTEMS, INC. PRODUCT PORTFOLIO 159
STRATEGY 159
ACTIVX BIOSCIENCES, INC. 160
TABLE 138 ACTIVX BIOSCIENCES, INC. PRODUCT PORTFOLIO 160
STRATEGY 160
AGILENT TECHNOLOGIES 161
TABLE 139 AGILENT TECHNOLOGIES PRODUCT PORTFOLIO 161
STRATEGY 161
TABLE 140 AGILENT TECHNOLOGIES STRATEGY 162
AMGEN, INC. 162
TABLE 141 AMGEN, INC. PRODUCT PORTFOLIO 162
TABLE 141 (CONTINUED) 163
STRATEGY 163
ANASPEC, INC. 163
TABLE 142 ANASPEC, INC. PRODUCT PORTFOLIO 164
STRATEGY 165
TABLE 143 ANASPEC, INC. STRATEGY 165
APPLIED BIOSYSTEMS INC. 166
TABLE 144 APPLIED BIOSYSTEMS INC. PRODUCT PORTFOLIO 166
STRATEGY 167
TABLE 145 APPLIED BIOSYSTEMS INC. STRATEGY 167
ASTERAND, PLC 167
TABLE 146 ASTERAND, PLC PRODUCT PORTFOLIO 168
STRATEGY 168
TABLE 147 ASTERAND, PLC STRATEGY 168
BAYER TECHNOLOGY SERVICES 169
TABLE 148 BAYER TECHNOLOGY SERVICES PRODUCT PORTFOLIO 169
STRATEGY 169
BECKMAN COULTER, INC. 170
TABLE 149 BECKMAN COULTER, INC. PRODUCT PORTFOLIO 170
STRATEGY 170
BECTON, DICKINSON, AND COMPANY (BD) 171
TABLE 150 BD PRODUCT PORTFOLIO 171
STRATEGY 171
BG MEDICINE 171
TABLE 151 BG MEDICINE PRODUCT PORTFOLIO 172
STRATEGY 172
TABLE 152 BG MEDICINE STRATEGY 172
BIACORE INTERNATIONAL AB 173
TABLE 153 BIACORE INTERNATIONAL AB PRODUCT PORTFOLIO 173
BIOCARTA, INC. 174
TABLE 154 BIOCARTA, INC. PRODUCT PORTFOLIO 174
BIO-RAD LABORATORIES, INC. 175
TABLE 155 BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO 175
TABLE 155 (CONTINUED) 176
STRATEGY 176
TABLE 156 BIO-RAD LABORATORIES, INC. STRATEGY 176
BRUKER BIOSCIENCES CORP. 177
TABLE 157 BRUKER BIOSCIENCES CORPORATION PRODUCT PORTFOLIO 177
STRATEGY 177
CALIPER LIFE SCIENCES INC. 178
TABLE 158 CALIPER LIFE SCIENCES INC. PRODUCT PORTFOLIO 178
STRATEGY 178
TABLE 159 CALIPER LIFE SCIENCES, INC. STRATEGY 179
CAPRION PROTEOMICS, INC. 179
TABLE 160 CAPRION PROTEOMICS, INC. PRODUCT PORTFOLIO 179
STRATEGY 180
CELLZOME AG 180
TABLE 161 CELLZOME AG PRODUCT PORTFOLIO 180
STRATEGY 180
COMMONWEALTH BIOTECHNOLOGIES, INC. 181
TABLE 162 COMMONWEALTH BIOTECHNOLOGIES, INC. PRODUCT PORTFOLIO 181
STRATEGY 181
DIGILAB BIOVISION GMBH 182
TABLE 163 DIGILAB BIOVISION GMBH PRODUCT PORTFOLIO 182
STRATEGY 182
TABLE 164 DIGILAB BIOVISION GMBH STRATEGY 183
DIONEX CORP. 183
TABLE 165 DIONEX CORP. PRODUCT PORTFOLIO 183
TABLE 165 (CONTINUED) 184
STRATEGY 184
TABLE 166 DIONEX CORP. STRATEGY 184
DUALSYSTEMS BIOTECH AG 185
TABLE 167 DUALSYSTEMS BIOTECH AG PRODUCT PORTFOLIO 185
STRATEGY 186
DYAX CORP. 186
TABLE 168 DYAX CORP. PRODUCT PORTFOLIO 186
STRATEGY 186
EPROGEN 187
TABLE 169 EPROGEN PRODUCT PORTFOLIO 187
STRATEGY 187
ERAGEN BIOSCIENCES 187
TABLE 170 ERAGEN BIOSCIENCES PRODUCT PORTFOLIO 188
STRATEGY 188
EUROGENTEC 188
TABLE 171 EUROGENTEC PRODUCT PORTFOLIO 189
STRATEGY 189
GE HEALTHCARE 190
TABLE 172 GE HEALTHCARE PRODUCT PORTFOLIO 190
TABLE 172 (CONTINUED) 191
STRATEGY 191
GENEART GMBH 192
TABLE 173 GENEART GMBH PRODUCT PORTFOLIO 192
STRATEGY 192
GENEDATA AG 192
TABLE 174 GENEDATA AG PRODUCT PORTFOLIO 193
STRATEGY 193
TABLE 175 GENEDATA AG STRATEGY 193
GENENTECH, INC. 194
TABLE 176 GENENTECH INC. PRODUCT PORTFOLIO 194
STRATEGY 194
TABLE 177 GENENTECH INC. STRATEGY 195
INTRINSIC BIOPROBES, INC. 195
TABLE 178 INTRINSIC BIOPROBES, INC. PRODUCT PORTFOLIO 195
STRATEGY 196
LIFESPAN BIOSCIENCES, INC. 196
TABLE 179 LIFESPAN BIOSCIENCES, INC. PRODUCT PORTFOLIO 196
STRATEGY 196
MATRITECH, INC. 197
TABLE 180 MATRITECH, INC. PRODUCT PORTFOLIO 197
STRATEGY 197
MATRIX SCIENCE, LTD. 197
TABLE 181 MATRIX SCIENCE, LTD. PRODUCT PORTFOLIO 198
STRATEGY 198
MDS, INC. 198
TABLE 182 MDS INC. PRODUCT PORTFOLIO 199
STRATEGY 199
MONARCH LIFESCIENCES 199
TABLE 183 MONARCH LIFESCIENCES PRODUCT PORTFOLIO 199
TABLE 183 (CONTINUED) 200
STRATEGY 200
NEXTGEN SCIENCES, LTD. 200
TABLE 184 NEXTGEN SCIENCES, LTD. PRODUCT PORTFOLIO 201
STRATEGY 201
NONLINEAR DYNAMICS, LTD. 202
TABLE 185 NONLINEAR DYNAMICS, LTD. PRODUCT PORTFOLIO 202
STRATEGY 202
TABLE 186 NONLINEAR DYNAMICS, LTD. STRATEGY 203
THERMO SCIENTIFIC OWL SEPARATION SYSTEMS 203
TABLE 187 THERMO SCIENTIFIC OWL SEPARATION SYSTEMS PRODUCT PORTFOLIO 203
STRATEGY 204
PERKINELMER, INC. 204
TABLE 188 PERKINELMER, INC PRODUCT PORTFOLIO 204
TABLE 188 (CONTINUED) 205
STRATEGY 205
TABLE 189 PERKINELMER, INC. STRATEGY 205
PROLEXYS PHARMACEUTICALS, INC. 205
TABLE 190 PROLEXYS PHARMACEUTICALS, INC. PRODUCT PORTFOLIO 206
STRATEGY 206
PROTAGEN AG 206
TABLE 191 PROTAGEN AG PRODUCT PORTFOLIO 207
STRATEGY 207
PROTEA BIOSCIENCES, INC. 207
TABLE 192 PROTEA BIOSCIENCES, INC. (USA) PRODUCT PORTFOLIO 207
STRATEGY 208
TABLE 193 PROTEA BIOSCIENCES, INC. (USA) STRATEGY 208
TYRIAN DIAGNOSTICS 208
TABLE 194 TYRIAN DIAGNOSTICS PRODUCT PORTFOLIO 208
STRATEGY 209
SHIMADZU BIOTECH 209
TABLE 195 SHIMADZU BIOTECH PRODUCT PORTFOLIO 209
TABLE 195 (CONTINUED) 210
STRATEGY 210
SOMALOGIC, INC. (USA) 210
TABLE 196 SOMALOGIC, INC. (USA) PRODUCT PORTFOLIO 211
STRATEGY 211
SYNGENE 211
TABLE 197 SYNGENE PRODUCT PORTFOLIO 212
THERMO FISHER SCIENTIFIC, INC. 212
TABLE 198 THERMO FISHER SCIENTIFIC INC. PRODUCT PORTFOLIO 213
TABLE 198 (CONTINUED) 214
STRATEGY 214
VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AUSTRIA) 214
TABLE 199 VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AUSTRIA) PRODUCT PORTFOLIO 215
STRATEGY 215
XENCOR, INC. 215
TABLE 200 XENCOR, INC. PRODUCT PORTFOLIO 215

Chapter-9: COMPANY PROFILES 57

Chapter-10: APPENDIX 15

APPENDIX ONE 216
- PROTEOMIC TECHNOLOGY PATENTS FOR THE U.S., EUROPE AND JAPAN 216
- TABLE 201 PROTEOMIC TECHNOLOGY PATENTS FOR THE U.S., EUROPE AND JAPAN 216
- TABLE 201 (CONTINUED) 217
- TABLE 201 (CONTINUED) 218
- TABLE 201 (CONTINUED) 219
- TABLE 201 (CONTINUED) 220
- TABLE 201 (CONTINUED) 221
- TABLE 201 (CONTINUED) 222
- TABLE 201 (CONTINUED) 223
- TABLE 201 (CONTINUED) 224
- TABLE 201 (CONTINUED) 225
- TABLE 201 (CONTINUED) 226
- TABLE 201 (CONTINUED) 227
APPENDIX TWO 228
- LIST OF ACRONYMS 228
- LIST OF ACRONYMS (CONTINUED) 229
- LIST OF ACRONYMS (CONTINUED) 230

Proteomics: Technologies and Global Markets

Table of Contents

Chapter-1: SUMMARY 2

Chapter-2: MARKET OVERVIEW 21

Chapter-3: GLOBAL PROTEOMICS EQUIPMENT MARKET 60

Chapter-4: PROTEOMICS TECHNOLOGY MARKET 18

Chapter-5: PROTEOMICS SERVICES MARKET 8

Chapter-6: PROTEOMICS DATABASE AND SOFTWARE MARKET 26

Chapter-7: PROTEOMICS APPLICATIONS MARKET 14

Chapter-8: GEOGRAPHIC ANALYSIS OF PROTEOMICS MARKET 5

Chapter-9: COMPANY PROFILES 57

Chapter-10: APPENDIX 15